The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Lower risk for cardiovascular mortality in oral 1 -hydroxy vitamin D3 users in a haemodialysis population
Open accessAbstract
BACKGROUND: Renal failure results in deficiency of active vitamin D3 that has diverse effects on metabolism and organ functions. Treatment with active forms of vitamin D(3) ameliorates abnormalities in bone and mineral metabolism, cardiac function, immune response and others. We hypothesized that treatment with vitamin D(3) may be beneficial for survival in patients with end-stage renal disease (ESRD). METHODS: We compared the risk of death between regular users (n = 162) and non-users (n = 80) of oral 1alpha-hydroxyvitamin D3 (alfacalcidol) in a cohort of ESRD patients undergoing haemodialysis for a follow-up of 61 +/- 23 months. The daily dose of alfacalcidol ranged from 0.25 to 1.5 microg, with a median of 0.5 microg. RESULTS: The alfacalcidol users showed a lower risk of death from cardiovascular disease than the non-users in a univariate Cox model [hazards ratio (HR) 0.287, 95% confidence interval (CI) 0.127-0.649, P = 0.003], whereas the risk for death from non-cardiovascular disease was not different between the two groups. Stepwise multivariate Cox analysis showed that cardiovascular mortality was significantly associated with age, presence of diabetes mellitus and treatment with alfacalcidol (HR 0.377, 95% CI 0.246-0.578, P = 0.022). CONCLUSIONS: These results indicate that use of oral alfacalcidol was associated with reduced risk for cardiovascular death in this cohort of ESRD patients. The result of this observational study warrants further randomized controlled trials with 1alpha-hydroxy vitamin D3 to confirm the possibility that such medication improves survival of ESRD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Norman, A. W. (1979) · Cited by 3,769
Block, G., Hulbert-Shearon, T., Levin, N., & Port, F. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531176 · Cited by 2,354
Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy
Teng, M., Wolf, M., Lowrie, E., Ofsthun, N., Lazarus, J. M., & Thadhani, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022536 · Cited by 927
Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure
Rostand, S. G., & Drüeke, T. B. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00575.x · Cited by 419
Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism
Ribeiro, S. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.8.2037 · Cited by 332
High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia
Kawagishi, T., Nishizawa, Y., Konishi, T., Kawasaki, K., Emoto, M., Shoji, T., Tabata, T., Inoue, T., & Morii, H. (1995) · Kidney International · doi:10.1038/ki.1995.356 · Cited by 311
Self-citationPark, C. W., Oh, Y. S., Shin, Y. S., Kim, C.-M., Kim, Y.-S., Kim, S. Y., Choi, E. J., Chang, Y. S., & Bang, B. K. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70260-x · Cited by 305
Jono, S., Nishizawa, Y., Shioi, A., & Morii, H. (1998) · Circulation · doi:10.1161/01.cir.98.13.1302 · Cited by 294
Self-citationWu, J., Garami, M., Cheng, T., & Gardner, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118582 · Cited by 257
Antibodies Against Oxidized LDL and Carotid Artery Intima-Media Thickness in a Healthy Population
Fukumoto, M., Shoji, T., Emoto, M., Kawagishi, T., Okuno, Y., & Nishizawà, Y. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.703 · Cited by 149
Self-citationImpaired metabolism of high density lipoprotein in uremic patients
Shoji, T., Nishizawa, Y., Nishitani, H., Yamakawa, M., & Morii, H. (1992) · Kidney International · doi:10.1038/ki.1992.238 · Cited by 123
Self-citationAntibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease
Shoji, T., Fukumoto, M., Kimoto, E., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00692.x · Cited by 56
Self-citationCoburn, J. W., & Frazão, J. M. (2002) · Springer eBooks · doi:10.1007/978-1-4471-0667-8_15 · Cited by 3
Cited by
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H. F., Lieben, L., Mathieu, C., & Demay, M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0004 · Cited by 1,783
25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population
Melamed, M. L., Michos, E. D., Post, W., & Astor, B. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1629 · Cited by 1,218
Vitamin D levels and early mortality among incident hemodialysis patients
Wolf, M., Shah, A., Gutierrez, O., Ankers, E., Monroy, M., Tamez, H., Steele, D., Chang, Y., Camargo, C. A., Tonelli, M., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002451 · Cited by 789
Activated Injectable Vitamin D and Hemodialysis Survival: A Historical Cohort Study
Teng, M., Wolf, M., Ofsthun, M. N., Lazarus, J. M., Hernán, M. A., Camargo, C. A., & Thadhani, R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070573 · Cited by 782
Xiang, W., Kong, J., Chen, S., Cao, L.-P., Qiao, G., Zheng, W., Liu, W., Li, X., Gardner, D. G., & Li, Y. C. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00224.2004 · Cited by 570
Metadata
- Authors
- Shoji, T., Shinohara, K., Kimoto, E., Emoto, M., Tahara, H., Koyama, H., Inaba, M., Fukumoto, S., Ishimura, E., Miki, T., Tabata, T., & Nishizawa, Y.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-01
- Volume
- 19
- Issue
- 1
- Pages
- 179-184
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2102185935
- Cited by
- 351
- References
- 13
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.